0       0

2019 Scientific Sessions On-Demand


SSLIVE23 - Late Breaking Science V: Challenges in Heart Failure Management


Nov 17, 2019 10:45am ‐ Nov 17, 2019 12:00pm


Credits: None available.

Description

Social Media ModeratorMark Drazner

Results From the Pediatric Heart Network’s Fonta n Udenafil Exercise Longitudinal TrialDavid Goldberg

DiscussantCraig Sable

Effect of Treatment According to Age in the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)Felipe Martinez

Effect of Treatment on the Kansas City Cardiomyopathy Questionnaire (KCCQ) in the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF) - John McMurray

DiscussantCarolyn Lam

LBCT: Effects of Sacubitril/Valsartan in Women Compared to Men With Heart Failure and Preserved Ejection Fraction - John McMurray

Effect of Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure - Scott Solomon

DiscussantLynne Stevenson

Putting It All Together: How to Use SGLT2 Inhibitors and ARNIs in PracticeClyde Yancy

Late Breaking Science V: Challenges in Heart Failure ManagementDiscussion

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content